Question 1

How many shares of CPRX does GEODE CAPITAL MANAGEMENT, LLC own?

Accepted Answer

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC holds 3.2M shares of CPRX (CATALYST PHARMACEUTICALS INC).

Question 2

What is GEODE CAPITAL MANAGEMENT, LLC's CPRX position worth?

Accepted Answer

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC's CPRX position is worth $99M.

Question 3

Is GEODE CAPITAL MANAGEMENT, LLC buying or selling CPRX?

Accepted Answer

In 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC increased their CPRX position (+6.0% change in shares).

Question 4

When did GEODE CAPITAL MANAGEMENT, LLC first buy CPRX?

Accepted Answer

Based on available 13F filings, GEODE CAPITAL MANAGEMENT, LLC first reported a position in CPRX in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	3.2M	+6.0%	$99M	0.0%	$31.43	32
2026-Q1	Increased	3M	+2.5%	$73.6M	0.0%	$23.92	30
2025-Q4	Increased	2.9M	+0.3%	$67.7M	0.0%	$23.29	30
2025-Q3	Increased	2.9M	+0.8%	$56.9M	0.0%	$19.55	30
2025-Q2	Increased	2.9M	+3.7%	$62.2M	0.0%	$21.78	31
2025-Q1	Increased	2.8M	+3.8%	$67.1M	0.0%	$24.69	31
2024-Q4	Increased	2.7M	+0.0%	$55.6M	0.0%	$21.07	29
2024-Q3	Decreased	2.7M	-1.3%	$53M	0.0%	$19.56	0